Daniel Morgensztern
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index50
i10-index138
Publications441
Citations20,806
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: Pharmacokinetics and pharmacodynamics of the GCN2 activator HC-7366 in a phase 1a study in patients with advanced solid tumors. (Journal of Clinical Oncology)2026-05-28
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current
Find elsewhere
ORCID: 0000-0003-4349-2028